OP7H:PA:PA-Ossiam Bloomberg USA PAB UCITS ETF - 1A EUR Hedged Acc (EUR)

ETF | Others |

Last Closing

USD 133.849

Change

0.00 (0.00)%

Market Cap

N/A

Volume

366.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.31 (-0.68%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-10.60 (-1.94%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-8.61 (-2.20%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-0.49 (-1.38%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.23 (+0.86%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-8.45 (-1.81%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

-5.39 (-1.55%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-1.17 (-2.12%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.27 (+3.67%)

USD 5.25B

ETFs Containing OP7H:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.75% 27% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.75% 27% F 31% F
Trailing 12 Months  
Capital Gain 10.60% 55% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.60% 54% F 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.24% 55% F 61% D-
Dividend Return 9.24% 53% F 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.12% 57% F 77% C+
Risk Adjusted Return 76.28% 54% F 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike